Presumed ocular histoplasmosis syndrome: Update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies

Current Opinion in Ophthalmology

Volumn 12, Issue 6, 2001, Pages 442-449

  Ciulla, Thomas A ^a   Piper, Heidi C ^a   Xiao, Matthew ^a   Wheat, L Joseph ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; BENZOPORPHYRIN DERIVATIVE; CORTICOSTEROID; LIPOSOME; MATRIX METALLOPROTEINASE INHIBITOR; PHOTOSENSITIZING AGENT; PREDNISONE; PRINOMASTAT; VASCULOTROPIN INHIBITOR;

ARGON LASER; CLINICAL FEATURE; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG EFFICACY; EYE SURGERY; GENE THERAPY; HISTOPLASMA CAPSULATUM; HUMAN; KRYPTON LASER; LASER COAGULATION; OCULAR HISTOPLASMOSIS; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETINA; RETINA SURGERY; REVIEW; SUBRETINAL NEOVASCULARIZATION;

ANGIOGENESIS INHIBITORS; CHOROID DISEASES; EYE INFECTIONS, FUNGAL; HISTOPLASMOSIS; HUMANS; LASER COAGULATION; OPTIC ATROPHY; PHOTOCHEMOTHERAPY; SYNDROME;

EID: 0035207523     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200112000-00009     Document Type: Review

References (72)

1. Follow-up study of presumed ocular histoplasmosis
2. Macular lesions in blacks with the presumed ocular histoplasmosis syndrome
3. Presumed histoplasmic choroiditis
4. Follow-up study of presumed ocular histoplasmosis syndrome
5. The etiology of the presumed ocular histoplasmosis syndrome
6. Presumed ocular histoplasmosis in the Netherlands-an area without histoplasmosis
7. Ocular histoplasmosis
8. Histoplasmosis-like choroiditis in a non-endemic area: The northwest United States
9. Histoplasmosis: Experience during outbreaks in Indianapolis and review of the literature
10. Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration
11. The development of an experimental model of subretinal neovascularization in disciform macular degeneration
12. Subretinal neovascularization: Natural history of an experimental model
13. Vascular casts of experimental subretinal neovascularization in monkeys: A preliminary report
14. Vascular casts of experimental subretinal neovascularization in monkeys
15. Experimental subretinal neovascularization in the monkey: Permeability of new vessels
16. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate
17. Morphologic observations on experimental subretinal neovascularization in the monkey
18. Pathogenesis of laser-induced choroidal subretinal neovascularization
19. Activated macrophages in experimental subretinal neovascularization
20. Pericytes of newly formed vessels in experimental subretinal neovascularization
21. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes
22. Pathophysiologic and histopathologic bases for interpretation of fluorescein angiography
23. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration
24. Surgical removal of subretinal hemorrhage and choroidal neovascular membranes in acute hemorrhagic age-related macular degeneration
25. Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration
26. A breakthrough in surgery for age-related macular degeneration?
27. Relation of the functional and structural fundus changes after submacular surgery for neovascular age-related macuclar degeneration
28. Visual results after surgical removal of subfoveal choroidal neovascular membranes
29. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome: Visual prognosis
30. The natural course of active choroidal lesions in the presumed ocular histoplasmosis syndrome
31. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis: Results of a randomized clinical trial
32. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis
33. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy
34. Argon laser photocoagulation for ocular histoplasmosis: Results of a randomized clinical trial
35. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: Results of a randomized clinical trial
36. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin
37. Verteporfrin (Visudyne) based photodynamic therapy for subfoveal choroidal neovascularization
38. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes
39. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes
40. Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts
41. Growth factor localization in choroidal neovascular membranes of age-related macular degeneration
42. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes
43. Distribution of growth factors in subfoveal neovascular membranes in age-related macular degeneration and presumed ocular histoplasmosis syndrome
44. Vascular endothelial growth factor expression in choroidal neovascularization in rats
45. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization
46. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate
47. Mechanisms of endothelial growth control
48. Approaches to studying cell adhesion molecules in angiogenesis
49. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
50. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes
51. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye
52. TIMP-3 in Bruch's membrane: Change during aging and in age-related macular degeneration
53. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases
54. Angiostatic steroids
55. The effect of angioatatic steroids and B-Cyclodextrin tetradecasulfate on corneal neovascularization in the rat
56. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization
57. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate
58. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model
59. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide
60. Exudative macular degeneration and intravitreal triamcinolone: A pilot study
61. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up
62. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration
63. Inhibition of intraocular tumor growth by topical application of the antiangiogenic steroid anecortave acetate
64. Vitreous surgery for hemorrhagic and fibrous complications of age-related macular degeneration
65. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome
66. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis
67. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: Stability of early visual results
68. Visual results after surgical removal of subfoveal choroidal neovascular membranes
69. Visual outcome after surgical removal of choroidal neovascularization in pediatric patients
70. Update on surgical removal of choroidal neovascularization
71. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration